ANAL CANCER
Clinical trials for ANAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ANAL CANCER trials appear
Sign up with your email to follow new studies for ANAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug trial halted early – what we know
Disease control TerminatedThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer that no longer responds to hormone therapy, as well as other solid tumors like melanoma and lung cancer. The goal was to see if the drug could shrink tumors or slow dis…
Matched conditions: ANAL CANCER
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug combo tested for tough cancers
Disease control TerminatedThis early-phase study tested a new drug called SO-C101, alone or with pembrolizumab, in 115 people with advanced solid tumors (like lung, kidney, or skin cancer) that stopped responding to standard treatments. The main goal was to check safety and find the right dose. The study …
Matched conditions: ANAL CANCER
Phase: PHASE1 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Battle of the scalpels: which technique removes early rectal cancer best?
Knowledge-focused TerminatedThis study compared two procedures for removing early-stage rectal cancer and non-cancerous growths: transanal endoscopic microsurgery (TEM), a surgical full-thickness removal, and endoscopic submucosal dissection (ESD), a scope-based technique that removes only the inner layers.…
Matched conditions: ANAL CANCER
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC